This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

Prices will rise in...

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

Christian Heinis, PhD
Associate Professor at Ecole PolyTechnique Federale de Lausanne
Speaker

Profile

Christian Heinis is involved in the discovery and development of cyclic peptides for therapeutic applications. His research group creates ligands based on cyclic peptides by synthesising large libraries of random peptides using combinatorial approaches and screening them for binding or modulation of disease targets. An important goal of his team is to develop cyclic peptides that are membrane-permeable and/or orally available.

Christian Heinis studied chemistry/biochemistry at ETH Zurich. After his PhD in the research group of Prof Dr Dario Neri at ETH Zurich, he did two post-docs, the first with Prof Dr Kai Johnsson at EPFL in Lausanne and the second with Sir Gregory Winter at LMB-MRC in Cambridge, UK. He joined EPFL in 2008 as an assistant professor and was promoted to associate professor in 2015. Christian Heinis is co-founder of the companies Bicycle Therapeutics and Orbis Medicines.

Agenda Sessions

  • Development of Membrane-Permeable Cyclic Peptides

    08:35